Exiting the founding camera business — selling Imaging to Japan Industrial Partners (2020)

The founding trade against the earnings

Olympus set out in 1919 as the microscope maker Takachiho Seisakusho, spread its name across the world with cameras, and put down deep roots in medicine with endoscopes. Selling the imaging business meant letting go of the most widely known to consumers of the three pillars built along that path. The Olympus Pen and the OM-D fell far short of the medical business in earnings, yet their value as a brand was large. President Yasuo Takeuchi’s “selection and concentration” was a judgment that put the business structure earning more than ninety percent of operating profit ahead of an emotional signboard.

Trace the founding trade and Olympus’s origin lies in the microscope. That microscope business, too, was let go in 2023 in the form of the sale of its science subsidiary Evident, and Olympus reshaped itself into a company dedicated to medical devices centred on endoscopes. The sale of the imaging business is the first step of that larger restructuring. To gather resources into the earning business even at the cost of cutting loose a long-cherished founding brand — selection and concentration forces the question of identity, of what a company keeps and what it discards. The founding signboard, or the business that generates profit: Olympus’s choice offers one answer to that tension.